There is a significant elevation in the interleukin-6 (IL-6), C-reactive protein (CRP), tumour necrosis factor-alpha (TNF-α) and IL-1β levels in preclinical diabetes samples. This evidence concerns the gene IL6 and diabetes mellitus.